AIDs

UK financial markets
#AIDs #Malaria #Tuberculosis #UK government

GSK and ViiV Healthcare invest £6 million in Global Fund

Pharmaceutical companies GSK and ViiV Healthcare have invested £6 million ($8 million) in the Global Fund to Fight AIDS, Tuberculosis and Malaria.  The investment will strengthen community-led responses to HIV, tuberculosis (TB) and malaria in lower income countries. The commitment will also be matched by the Gates… Read More

#News

AIDS
#AIDs #American Association of Pharmaceutical Scientists #Cambridge Crystallographic Data Centre #Collaboration #Pharmaceuticals #Research

CCDC AIDS research wins AAPS pharma award 

A Cambridge Crystallographic Data Centre (CCDC) research paper has won an Outstanding Manuscript Award from the American Association of Pharmaceutical Scientists (AAPS).  The research paper, Solid-State and Surface Structures of the Conformational Polymorphic Forms of Ritonavir in Relation to their Physicochemical Properties, published in the… Read More

#News